Contract award · 28 Apr 2025

CA02825 Ixekizumab (Taltz®)

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") awarded a contract to Eli Lilly and Company Ltd for £1.14m…

No competitionMedical equipment & pharmaceuticalsScotland

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Value
£1,142,153
Procedure
Award procedure without prior publication of a call for competition
Sector
Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
Region
Scotland
Timeline
  1. Contract date28 Apr 2025
  2. Published30 Apr 2025Published 2 days after the contract date

Description

Supply of Ixekizumab (Taltz®) to NHS Scotland. The Authority has awarded this framework as a single supplier framework agreement to one (1) Framework Participant.

About the supplier

More from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

All contracts

More won by Eli Lilly and Company Ltd

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview